Delivery Order SPE2DB22D1017-SPE2DB25FG4AF
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for the supply of Modafinil 100 mg tablets in 30-count units. The contract is valued at $2,180.51 under a firm fixed-price arrangement with an ultimate completion date of September 24, 2025. This non-set-aside award was competitively awarded and represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for Modafinil 100 mg tablets (30-count units) with a ceiling value of $2,251.20. This is a firm fixed price, non-set-aside contract awarded on August 20, 2025, with an ultimate completion date of August 21, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 with a ceiling value of $11,287.97. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The contract is set to be completed by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Modafinil 100 mg tablets in 30-count units, with a ceiling value of $6,926.27. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $4,621.97 and firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $7,199.01, is scheduled for completion by August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order for Modafinil 100 mg tablets (quantity 30s) by the Defense Logistics Agency on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract is valued at $3,939.53 and is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $11,943.31. This delivery order represents a firm fixed price contract with a completion date of September 12, 2025, and is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for the supply of Modafinil 100 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $13,506.96 with a firm fixed price structure and is scheduled for completion by September 22, 2025. The award was issued on September 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Modafinil 100 mg tablets in unit dose packaging of 30 units. This non-set-aside, competitively awarded contract carries a ceiling value of $4,150.99 under a firm fixed price arrangement, with an ultimate completion date of September 29, 2025. The contract is performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4AFDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 2, 2025, by the Defense Logistics Agency (DLA) for the supply of Modafinil 100 mg tablets in quantities of 30s. This is a firm fixed-price delivery order with a ceiling value of $7,977.19 and an ultimate completion date of June 3, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, PA, the company's corporate headquarters, which also serves as a primary distribution point for federal medical procurement. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical commodities to support military healthcare programs globally. Modafinil, a wakefulness-promoting agent commonly used in military and veteran healthcare settings, represents one of the specialized pharmaceutical products delivered through this contract vehicle to support Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 6/2/25 |